First Generation of Controlled-Release Bacteriocins/Anti-Microbials

Award Information
Agency: Department of Defense
Branch: Army
Contract: W911QY-12-P-0123
Agency Tracking Number: A113-127-0264
Amount: $99,969.00
Phase: Phase I
Program: SBIR
Awards Year: 2012
Solicitation Year: 2011
Solicitation Topic Code: A11-127
Solicitation Number: 2011.3
Small Business Information
Metna Co.
1926 Turner Street, Lansing, MI, -
DUNS: 968332846
HUBZone Owned: N
Woman Owned: Y
Socially and Economically Disadvantaged: N
Principal Investigator
 Jue Lu
 Director of Product Development
 (517) 485-1402
 jlmetnaco@gmail.com
Business Contact
 Parviz Soroushian
Title: President
Phone: (517) 485-9583
Email: metnaco@gmail.com
Research Institution
 Stub
Abstract
Food safety has become an increasingly important international concern; it is also a critical issue for the Warfighter who is encountering growing bioterrorism and proliferation of foodborne illnesses. Biopreservation is a technique used to increase shelf life and food safety through natural, biological methods, and could resolve some major food-related issues. Among the wide spectrum of antibacterial products based on microorganisms, the bacteriocins have attracted the greatest attention for food preservation; their use, however, is still limited due to complicated factors, including interaction with the foods, low solubility at high pH, and short shelf life. This project will develop and commercialize a new generation of controlled-release bacteriocins/anti-microbials with nanoencapsulation using biodegradable polymers to advance biopreservation for improving food safety. The project will specifically target effective inhibition of a broad range of spoilage bacteria, pathogens and spores over the extended shelf life of ration components used for military feeding. The following objectives will be achieved in the Phase I effort: i) identification of viable potential bacteriocins/anti-microbials complexes for effective killing of both Gram-negative and Gram-positive foodborne pathogens; ii) development of nanoencapsulated bacteriocins/anti-microbials, and thorough assessment of their antimicrobial activity; and iii) modeling the in-vitro release of nanoencapsulated bacterocins/anti-microbials.

* information listed above is at the time of submission.

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government